Drug Profile


Alternative Names: SPD 493; TV 1901; TVP 1901; Valproyl glycinamide; VGD

Latest Information Update: 11 Mar 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Hebrew University of Jerusalem
  • Class Antiepileptic drugs; Neuroprotectants
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued CNS disorders; Epilepsy

Most Recent Events

  • 21 Feb 2008 Discontinued - Phase-I for CNS disorders in USA (PO)
  • 09 Mar 2007 Phase-I clinical trials in CNS disorders in USA (PO)
  • 04 Jul 2005 Discontinued - Phase-II for Epilepsy in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top